DEUTSCHE BANK AG\
BankPosition in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in MRVI
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$26,862,744
+$24,433,883 QoQ
Shares Held
4,304,927
+401.6% QoQ
Ownership
1.66%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#9
of 177 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. MRVI ranks #15 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in MRVI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,862,744 | 4,304,927 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $2,428,861 | 858,255 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,754,475 | 847,531 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,418,692 | 1,888,046 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,517,166 | 1,874,343 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,579,647 | 2,072,239 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $6,739,681 | 1,236,639 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $15,507,581 | 1,866,135 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $11,648,009 | 1,626,817 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $12,263,992 | 1,414,532 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $9,265,184 | 1,414,532 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $245,090 | 24,509 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $18,138,662 | 1,459,265 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,955,722 | 282,350 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,085,012 | 75,822 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $154,813 | 6,064 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $165,828 | 5,837 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $162,594 | 4,610 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $999,901 | 23,864 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $37,436,111 | 762,757 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $3,077,250 | 73,742 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,416,377 | 95,858 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,513,269 | 53,949 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||